The DEA recently announced that, effective 10/31/2021, it is shifting its DEA Form 222 from a triplicate-paper to a single sheet for controlled substance schedules 1, 2 and 2N.
For more information, please visit DEA's Diversion Control Division website (at link above) or contact Isabel Weber at the Controlled Substances Program: isabel.weber@colorado.edu.